Matinas BioPharma agrees to merge with GH Power in NYSE American listing deal

• GH Power signed a definitive business combination agreement with Matinas BioPharma (MTNB) to take GH Power public on the NYSE American.
• Upon closing, GH Power is expected to become a wholly owned subsidiary of a new Ontario parent, GH Power International.
• Existing GH Power shareholders are expected to hold about 91% of GH Power International’s equity at closing, subject to adjustments.
• The transaction is positioned to fund commercialization of GH Power’s modular reactor technology and a broader clean energy and critical materials pipeline.
• Closing remains subject to shareholder, regulatory, court, financing, and exchange approvals and other conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Matinas BioPharma Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260730266947) on July 30, 2026, and is solely responsible for the information contained therein.